Trondheim, Norway

Martin Gimmestad

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Fmc Biopolymer as. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin Gimmestad. Retrieved from https://idiyas.com/inventor/martin-gimmestad

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0



Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Martin Gimmestad

Introduction: Martin Gimmestad is a notable figure in the realm of scientific research and development in Norway. Currently working at Algipharma AS, he has dedicated his career to advancing pharmaceutical innovations. Although he has not yet filed for patents, his contributions to the industry are noteworthy.

Latest Patents: As of now, Martin Gimmestad holds no patents. However, his involvement in the pharmaceutical sector suggests a potential for future innovations that may contribute to advancements within his field.

Career Highlights: Working at Algipharma AS, Martin has engaged in various projects that reflect his dedication to improving drug formulations and development processes. His expertise in the pharmaceutical industry has been a vital asset to the company, bringing valuable insights and strategies to tackle complex challenges.

Collaborations: Martin frequently collaborates with his coworker, Karianne Bakkevig, among others at Algipharma AS. Together, they explore the frontiers of pharmaceutical research, leveraging their combined knowledge to drive innovative solutions within the company.

Conclusion: Martin Gimmestad’s journey in the pharmaceutical space highlights the importance of collaboration and dedication in innovation. While he has not yet secured patents, his work at Algipharma AS positions him as a promising contributor to future advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…